Navigation Links
eResearchTechnology Reports Fourth Quarter and Full Year 2007 Results
Date:2/26/2008

p> Preferred stock-$10.00 par value, 500,000

shares authorized, none issued and outstanding - -

Common stock-$.01 par value, 175,000,000 shares

authorized, 58,356,546 and 58,870,291 shares

issued, respectively 584 589

Additional paid-in capital 83,493 87,957

Accumulated other comprehensive income 1,510 1,679

Retained earnings 70,225 85,477

Treasury stock, 8,247,119 shares at cost (62,190) (62,190)

Total stockholders' equity 93,622 113,512

Total liabilities and stockholders'

equity $115,064 $147,696

eResearchTechnology, Inc. and Subsidiaries

Consolidated Statements of Cash Flows

(in thousands)

Year Ended December 31,

2006 2007

(unaudited)

Operating activities:

Net income $8,310 $15,252

Adjustments to reconcile net income to net

cash provided by operating activities:

Depreciation and amortization 11,253 15,129

Cost of sales of equipment 3,722 1,143

Provision for uncollectible accounts 111 30

Share-based compensation 2,975 2,004

Investment impairment charge 226 -

Changes in operating assets and liabilities

exclusive of CCSS acquisition:

Accounts receivable (2,56
'/>"/>

SOURCE eResearchTechnology, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. eResearchTechnology to Present at the Thomas Weisel Healthcare Conference 2007 on September 5th
2. eResearchTechnology to Present at the UBS Global Healthcare Services Conference 2008 on February 11th
3. eResearchTechnology, Inc. to Announce 2007 Fourth Quarter Results on February 26, 2008
4. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
5. QMed, Inc. Reports July Medicare SNP Enrollments
6. Phlo Affiliate Reports Expanded Coverage to Oregon Border
7. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
8. Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007
9. Carrington Reports Second Quarter 2007 Results
10. Avitar Reports Third Quarter Financial Results for Fiscal 2007
11. Response Genetics Reports Second Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/1/2015)... 1, 2015 Emerson Ecologics is excited to ... of Better Medicine . The conference will provide integrative ... a thriving and fulfilling practice. Scheduled ... Resort and Spa, the conference will be a one-of-a-kind, ... accomplish key projects and leave with an action plan ...
(Date:4/1/2015)... - Portage Biotech Inc. ("Portage") (OTC Market: PTGEF, ... that Biohaven Pharmaceutical Holding Company Limited (Biohaven), which ... agreement with inVentiv Health for the operational execution ... compound (BHV-0223). Biohaven is engaged ... neuroscience compounds targeting the glutamatergic system. Clinical drug ...
(Date:4/1/2015)... - Canada,s Research-Based Pharmaceutical Companies (Rx&D) ... report on Cost Drivers of Public Drug Plans in ... report, the rates of change in drug costs have been ... percent in 2012/13 for a number of select public drug ... costs of medicines without considering their overall impact on the ...
(Date:4/1/2015)... Los Angeles, CA (PRWEB) April 01, 2015 ... portable reader that can read both chromatographic and fluorescent ... a leading supplier of high performance, quantitative readers and ... readers globally. The HRDR-400 is a first of its ... capabilities in one instrument. , Dr. Neven Karlovac, ...
Breaking Biology Technology:Emerson Ecologics Announces First Annual Conference for Integrative Healthcare Practitioners 2Emerson Ecologics Announces First Annual Conference for Integrative Healthcare Practitioners 3Portage's Biohaven Announces Agreement with inVentiv Health 2Portage's Biohaven Announces Agreement with inVentiv Health 3Rx&D responds to PMPRB report: overall impact of medicines must always be considered 2Holomic to Introduce the First Dual, Chromatographic and Fluorescent Rapid Test Reader, the HRDR-400 2
... Israel, December 2 InSightec Ltd. announced,today that ... with the ExAblate(R) system has the potential to ... have spread to,the bones (bone metastases). The results ... 11 online issue of Annals of Surgical Oncology, ...
... NicOx S.A.,(NYSE Euronext Paris: COX) today announced ... the commercial manufacture and supply of naproxcinod ... is NicOx, lead,investigational product and the first ... of,anti-inflammatory agents, which recently achieved positive results ...
... BASKING RIDGE, N.J., Dec. 2 Regado Biosciences, Inc., ... newly created position of Senior Vice President of Business ... McDonald brings to Regado nearly 20 years of experience ... operations, portfolio management and marketing. She will report ...
Cached Biology Technology:New Publications Show Noninvasive Magnetic Resonance-Guided Focused Ultrasound to be a Potentially Safe, Effective Pain-Relieving Treatment for Bone Metastases 2New Publications Show Noninvasive Magnetic Resonance-Guided Focused Ultrasound to be a Potentially Safe, Effective Pain-Relieving Treatment for Bone Metastases 3New Publications Show Noninvasive Magnetic Resonance-Guided Focused Ultrasound to be a Potentially Safe, Effective Pain-Relieving Treatment for Bone Metastases 4NicOx Signs Agreement With DSM for the Commercial Manufacture of Naproxcinod Drug Substance 2NicOx Signs Agreement With DSM for the Commercial Manufacture of Naproxcinod Drug Substance 3NicOx Signs Agreement With DSM for the Commercial Manufacture of Naproxcinod Drug Substance 4Ellen McDonald Joins Regado Biosciences as Senior Vice President of Business Operations and Chief Business Officer 2
(Date:3/23/2015)... BOSTON, Mass , March 23, 2015 SoundView ... shipment of NXT-ID,s (NASDAQ: NXTD ) Wocket smart wallet. SoundView ... world user feedback on their experience with the Wocket in ... experience at CVS, Whole Foods and other retailers, making both ... Kris Tuttle also says, "If the company meets ...
(Date:3/20/2015)... Mar. 19, 2015 Research and Markets ( ... Geometry - Global Strategic Business Report" report to their ... Hand Geometry in US$ Thousands. The report provides separate comprehensive ... Japan , Europe , ... and Rest of World. Annual estimates and forecasts ...
(Date:3/17/2015)... 17, 2015 MedNet Solutions , ... clinical study management systems, is pleased to announce ... ARENA,s Outsourcing in Clinical Trials Southeast conference – ... an excellent forum for MedNet to showcase ... software-as-a-service (SaaS) eClinical technology platform. We ...
Breaking Biology News(10 mins):Technology Research Note Update from SoundView; Real-World Usage and Feedback of Wocket Smart Wallet at CVS, Whole Foods and other Retailers 2Technology Research Note Update from SoundView; Real-World Usage and Feedback of Wocket Smart Wallet at CVS, Whole Foods and other Retailers 3Technology Research Note Update from SoundView; Real-World Usage and Feedback of Wocket Smart Wallet at CVS, Whole Foods and other Retailers 4Hand Geometry - Global Strategic Business Report 2015: An Essential Security Component for both Government & Enterprise Sector 2Hand Geometry - Global Strategic Business Report 2015: An Essential Security Component for both Government & Enterprise Sector 3Hand Geometry - Global Strategic Business Report 2015: An Essential Security Component for both Government & Enterprise Sector 4Connect With MedNet Solutions At Outsourcing In Clinical Trials Southeast 2
... SALT LAKE CITYLeukemia is the most common childhood cancer; ... zebrafish at Huntsman Cancer Institute (HCI) at the University ... in T-cell acute lymphocytic leukemia (T-ALL), according to an ... research journal Oncogene . When compared to samples ...
... to humans, the bacteria and tiny plants living in the ... is quite different than ours for one, they can,t ... red meat for a pick-me-up. So where does their ... " points to a source on the seafloor: minute particles ...
... a specific sugar residue on the cell surface, which is ... Faissner has now been able to use LewisX for the ... researchers report on their results in the Journal of ... Antibodies that recognise the LewisX sugar residue are used routinely ...
Cached Biology News:Zebrafish models identify high-risk genetic features in leukemia patients 2As good as gold 2
Cell Culture Flask, 25 cm, tissue-culture treated polystyrene...
Automated Cell Culture Flask...
... fluidics (HTF) system, 100-240 V, is an ... system that automates delivery of up to ... Bio-Plex array reader. The HTF system automatically ... sheath container to constantly maintain a reservoir ...
... In virtually every research laboratory, the revolutionary ... information accurately, inexpensively and in real time ... lab analysis system includes the Luminex 100, ... utilizes xMAP technology which enables you to ...
Biology Products: